AI Drug Monitoring vs. Traditional Media Monitoring: What Pharma Teams Are Missing
For the better part of three decades, pharmaceutical companies have monitored what the world says about their drugs through the […]
For the better part of three decades, pharmaceutical companies have monitored what the world says about their drugs through the […]
There’s a certain phase every drug eventually enters once it escapes the controlled environment of clinical trials and lands in
Inside the internet’s endless search for “Can I take this every day forever?” There’s a particular kind of pharmaceutical question
A parent in Texas asks ChatGPT how much ibuprofen to give her 18-month-old. ChatGPT returns a dose calculated for a
The shift happened without a product launch, without a press release, and without a single pharmaceutical company authorizing it. Sometime
Walk into any pharmaceutical compliance team’s weekly meeting and you’ll find the same agenda items from the past decade: OPDP
There’s a revealing pattern hidden inside patient search behavior. It’s not the ultra-rare oncology agents or impossible-to-pronounce biologics generating the
Why migraine drugs became weight-loss forums, cholesterol pills turned into food-interaction experiments, and cancer therapies spawned Reddit-scale crowdsourced medicine. There’s
Inside the wonderfully unfiltered world of drug questions people actually ask online Spend enough time around pharmaceutical R&D and you
Pfizer paid $2.3 billion in 2009. GlaxoSmithKline paid $3 billion in 2012. AstraZeneca paid $520 million in 2010. Each of
On September 30, 2004, Merck pulled Vioxx from every pharmacy shelf in the world. The withdrawal took less than 24
There’s a repeating theme across DrugChatter: not “what are the side effects?” but “is this normal—or something I should worry
Get sharp analysis on AI-generated drug information, off-label curiosity, pharmacovigilance blind spots, and the shifting intersection of pharma, search, and large language models. No fluff. Just the signals that matter.